Phaseline

Companies › Anhui Palo Alto Pharmaceuticals

Anhui Palo Alto Pharmaceuticals: clinical trials, targets and expected readouts

1 active drug program in 2 registered trials: 2 Phase 2; Respiratory.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
PA9159
Corticosteroid
–Phase 2Bronchial Asthma–

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07326995PA9159Phase 2Bronchial AsthmaRespiratoryFeb 2026
NCT07324707PA9159Phase 2Bronchial AsthmaRespiratoryMar 2026

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Expedition Therapeutics Dragonboat Biopharmaceutical Company Kinaset Therapeutics Melius Pharma Jianmin Pharmaceutical Group

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.